Organization
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL
2 abstracts
Abstract
A randomized, double-blind, placebo-controlled phase II study of adjuvant pembrolizumab versus placebo in patients with head and neck squamous cell cancers at high risk for recurrence: The PATHWay study.Org: Department of Medicine, University of Chicago, Johns Hopkins Medicine, University of Pennsylvania, Emory University Winship Cancer Institute, Hollings Cancer Center,
Abstract
The clinical relevance of margins in frameless stereotactic radiosurgery for intact brain metastases: A randomized trial of 0 vs 2 mm margins.Org: Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, Department of Radiation Oncology, University of Chicago, Chicago, IL, University of California, San Francisco, San Francisco, CA, The University of Chicago, Chicago, IL, Wilmot Cancer Institue, Rochester, NY,